Key Insights

Highlights

Related Conditions

Often studied with 14 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Research Network

Active Sponsors

  • University of Zagreb1

Top Investigators

Related Conditions

  • Patients Reported Outcomes1
  • Edentulism1
  • Oral Health Quality Of Life Ohqol Was Assessed1
  • Partial Edentulism1
  • Prosthodontics1

Activity Timeline